 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
|
|
|
|
Phase III
|
|
|
|
GOG-0209
GOG-0209, NCT00063999
|
|
| |
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
|
|
|
|
Phase II, Phase I
|
|
|
|
GYN03-0177
NCT00506779
|
|
| |
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer
|
|
|
|
Phase II
|
|
|
|
UTHSC-MS-96205
NCI-V97-1356, NCT00003135
|
|
| |
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
|
|
|
|
Phase II
|
|
|
|
UMN-2004LS021
UMN-WCC-38, NCT00258362
|
|
| |
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
|
|
|
|
Phase II
|
|
|
|
MMC-01-09-227
NCT00231868
|
|
| |
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
|
|
|
|
Phase II
|
|
|
|
06US03IMP-852A [Cooley]
MT2006-02, NCT00319748
|
|
| |
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
|
|
|
|
Phase II
|
|
|
|
05-402
NCT00322881
|
|
| |
Sunitinib in Treating Patients With Recurrent or Metastatic Endometrial Cancer
|
|
|
|
Phase II
|
|
|
|
PMH-PHL-062
7713, PHL-062, NCT00478426
|
|
| |
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
|
|
|
|
Phase II
|
|
|
|
2003-0823
NCT00388154
|
|
| |
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
|
|
|
|
Phase II
|
|
|
|
CINJ-3330
NCT00161187
|
|
